VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension

BACKGROUND: Pulmonary Arterial Hypertension (PAH) remains a therapeutic challenge, and the search continues for more effective drugs and drug combinations. We recently reported that deletion of the vasoactive intestinal peptide (VIP) gene caused the spontaneous expression of a PH phenotype that was...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hamidi, Sayyed A, Lin, Richard Z, Szema, Anthony M, Lyubsky, Sergey, Jiang, Ya Ping, Said, Sami I
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3210095/
https://ncbi.nlm.nih.gov/pubmed/22029879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-141
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi